|
|
|
| Effect of low-dose Colchicine on myocardial fibrosis in patients with primary hypertension complicated with hyperuricemia |
| LI Zelun1 WU Jieying2 FENG Yanling3 HUANG Bingsheng3 ZHANG Peng3 CHENG Ying |
1.Department of Critical Care Medicine,Panyu Maternal and Child Care Service Centre of Guangzhou,Panyu District He Xian Memorial Hospital,Guangdong Province,Guangzhou 511400,China;
2.Department of Radiology,Panyu Maternal and Child Care Service Centre of Guangzhou,Panyu District He Xian Memorial Hospital,Guangdong Province,Guangzhou 511400,China;
3.Department of Cardiovascular Medicine,Panyu Maternal and Child Care Service Centre of Guangzhou,Panyu District He Xian Memorial Hospital,Guangdong Province,Guangzhou 511400,China |
|
|
|
|
Abstract Objective To explore the effect of low-dose Colchicine on myocardial fibrosis in patients with primary hypertension complicated with hyperuricemia.Methods A total of 100 patients with primary hypertension complicated with hyperuricemia treated in Panyu Maternal and Child Care Service Centre of Guangzhou from January 2017 to June 2020 were selected as the research objects.According to random number table method,they were divided into control group (n=50) and observation group (n=50).Both groups were given routine antihypertensive and uric acid treatment.On this basis,the observation group was treated with low-dose Colchicine and the control group was treated with placebo.The levels of uric acid,high sensitivity C-reactive protein (hs-CRP) and related indexes of myocardial fibrosis(osteopontin [OPN],transforming growth factor β1 [TGF-β1],plasminogen activator blocking factor-1 [PAI-1],type Ⅰprocollagen carboxy terminal peptide [PⅠCP],type Ⅰprocollagen carboxy terminal cross-linking peptide [CⅠTP],type Ⅲprocollagen amino terminal peptide [PⅢNP]) were compared between the two groups before and after treatment.The left ventricular end diastolic diameter (LVEDD),left ventricular end systolic diameter (LVESD) and left ventricular ejection fraction (LVEF) were compared between the two groups before and after treatment.Results After 6 months and 12 months of treatment,uric acid and hs-CRP in the observation group were lower than those in the control group,with statistically significant differences (P＜0.05).After 12 months of treatment,the levels of OPN,TGF-β1,PAI-1,PⅠCP,CⅠTP and PⅢNP in the observation group were lower than those in the control group,with statistically significant differences (P＜0.05).After 12 months of treatment,LVEDD and LVESD in the observation group were lower than those in the control group,and LVEF was higher than that in the control group,with statistically significant differences (P＜0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P＞0.05).Conclusion Low-dose Colchicine can effectively delay myocardial fibrosis in patients with primary hypertension complicated with hyperuricemia.It has high security.
|
|
|
|
|
|
| [1] |
朱令圆，方园，曹智贤，等.睡眠时间和睡眠质量对我国中老年人高血压的发病率的影响[J].中华疾病控制杂志，2020，24（2）：58-64.
|
| [2] |
庞敏霞，方颖莹，陈素红，等.高尿酸血症的危害及中药防治特点的研究进展[J].中华中医药学刊，2017，35（2）：340-344.
|
| [3] |
张晓丹，赵红丽，姚敏，等.高血压患者尿酸水平与左心室肥厚及心肌纤维化的相关性研究[J].航空航天医学杂志，2019，30（11）：1307-1308，1393.
|
| [4] |
刘云洁，邱季合并高血压的高尿酸血症药物治疗进展[J].实用药物与临床，2017，20（10）：1212-1215.
|
| [5] |
Demidowich AP，Davis AI，Dedhia N，et al.Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation[J].Med Hypotheses，2016，92：67-73.
|
| [6] |
Wang Y，Viollet B，Terkeltaub R，et al.AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages[J].Ann Rheum Dis，2016，75（1）：286-294.
|
| [7] |
《中国高血压防治指南》修订委员会.中国高血压防治指南：2005年修订版[M].北京：人民卫生出版社，2006.
|
| [8] |
徐小明，邱倩，高翔，等.厄贝沙坦联合苯磺酸氨氯地平对老年糖尿病高血压合并高尿酸血症患者的疗效研究[J].河北医学，2016，22（5）：764-766.
|
| [9] |
心血管疾病合并高尿酸血症诊治专家共识专家组.无症状高尿酸血症合并心血管疾病诊治建议中国专家共识[J].心脑血管病防治，2010，10（4）：253-256.
|
| [10] |
杜秀娟，孙红凤.原发性高血压伴高尿酸血症的治疗进展[J].当代医学，2019，25（17）：187-188.
|
| [11] |
Pei L，Shu S，Wang X，et al.Effect of chrysanthemum extract on myocardial fibrosis in rats with renovascular hypertension[J].J Tradit Chin Med，2019，39（4）：96-103.
|
| [12] |
Rosin NL，Sopel MJ，Falkenham A，et al.Disruption of Collagen Homeostasis Can Reverse Established Age-Related Myocardial Fibrosis[J].Am J Pathol，2015，185（3）：631-642.
|
| [13] |
俞子恒，韦凡平，程震锋.小剂量秋水仙碱对不稳定心绞痛合并高尿酸患者胸痛改善的作用[J].中国临床药理学与治疗学，2016，21（4）：455-457.
|
| [14] |
姚国泰，黎娟，陈励.秋水仙碱在心血管疾病方面的研究进展[J].心脏杂志，2016，28（4）：483-487.
|
| [15] |
高磊，王立友，雷韵祎，等.组织非特异性碱性磷酸酶与心肌梗死后心肌纤维化的相关性研究[J].第三军医大学学报，2020，42（11）：1072-1077.
|
| [16] |
刘云青，胡丐锋，徐鸿轩，等.尿酸上调心脏成纤维细胞骨桥蛋白表达促使细胞增殖及胶原蛋白分泌[J].中国心血管杂志，2021，26（3）：266-271.
|
| [17] |
Engebretsen KV，Skardal K，Bjornstad S，et al.Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16，an orally active inhibitor of ALK5[J].J Mol Cell Cardiol，2014，26：148-157.
|
| [18] |
孙英杰，张文博，程敬亮，等.心脏磁共振评价扩张型心肌病患者心肌纤维化和左心室功能[J].中国医学影像技术，2016，32（6）：866-870.
|
|
|
|
